Price T Rowe Associates Inc Takeda Pharmaceutical CO LTD Transaction History

Price T Rowe Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$13.17 - $16.4 $72.7 Million - $90.5 Million	-5,518,932 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $2.16 Million - $2.29 Million	132,629 Added 2.46%	5,518,932 $90.4 Million
Q2 2021 Aug 16, 2021	SELL	$16.55 - $18.64 $837,347 - $943,090	-50,595 Reduced 0.93%	5,386,303 $90.7 Million
Q1 2021 May 17, 2021	BUY	$16.71 - $19.9 $1.24 Million - $1.48 Million	74,254 Added 1.38%	5,436,898 $99.3 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $18.97 $82.5 Million - $102 Million	5,362,644 New	5,362,644 $97.6 Million

335

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $40.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.